The Intrinsic Capacity (IC) Clock, a novel blood-based epigenetic clock, revolutionizes aging research by focusing on overall functional capacity involved in the aging process.
Unlike conventional clocks, the IC Clock measures intrinsic capacity, encompassing critical domains like mobility, cognition, mental health, vision, hearing, and nutrition/vitality.
It reflects how well an individual ages functionally, promising personalized medicine and public health advancements.
Developed by experts at the Buck Institute for Research on Aging, the IC Clock utilizes DNA methylation patterns to predict functional aging.
It outperforms previous aging clocks in predicting all-cause mortality and correlates with enhanced immune function and favorable lifestyle factors.
Efforts are underway to adapt the IC Clock for dried blood spot (DBS) assays, enabling broader deployment in low- and middle-income countries.
Despite WHO recognition, regulatory acceptance of intrinsic capacity decline remains a challenge, hindering clinical translation efforts.
The IC Clock's integration into the XPRIZE Healthspan competition aims to extend human healthspan and validate precision aging medicine.
This transformative research underscores the importance of longitudinal studies in unraveling the complexities of aging biology.
Overall, the IC Clock offers a biologically grounded, scalable tool for assessing intrinsic capacity and holds promise for managing aging proactively on a global scale.